{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T11:06:43Z","timestamp":1779361603036,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,21]]},"DOI":"10.7759\/cureus.109335","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T10:28:42Z","timestamp":1779359322000},"source":"Crossref","is-referenced-by-count":0,"title":["Maternal Serum Homocysteine as a Severity-Linked Biomarker Across the Spectrum of Hypertensive Disorders of Pregnancy: A Prospective Observational Study"],"prefix":"10.7759","author":[{"given":"Mouli","family":"Nandi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rana","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-020-01070-0","article-title":"Hypertension during pregnancy","volume":"22","author":"Agrawal A","year":"2020","unstructured":"Agrawal A, Wenger NK. Hypertension during pregnancy. Curr Hypertens Rep. 2020, 22:64. 10.1007\/s11906-020-01070-0","journal-title":"Curr Hypertens Rep"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118776","article-title":"The oxidant stress of hyperhomocyst(e)inemia","volume":"98","author":"Loscalzo J","year":"1996","unstructured":"Loscalzo J. The oxidant stress of hyperhomocyst(e)inemia. J Clin Invest. 1996, 98:5-7. 10.1172\/JCI118776","journal-title":"J Clin Invest"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k3478","article-title":"Effect of high dose folic acid supplementation in pregnancy on pre-eclampsia (FACT): double blind, phase III, randomised controlled, international, multicentre trial","volume":"362","author":"Wen SW","year":"2018","unstructured":"Wen SW, White RR, Rybak N, et al.. Effect of high dose folic acid supplementation in pregnancy on pre-eclampsia (FACT): double blind, phase III, randomised controlled, international, multicentre trial. BMJ. 2018, 362:k3478. 10.1136\/bmj.k3478","journal-title":"BMJ"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000003892","article-title":"Gestational hypertension and preeclampsia: ACOG practice bulletin summary, number 222","volume":"135","author":"American College of Obstetricians and Gynecologists","year":"2020","unstructured":"American College of Obstetricians and Gynecologists. Gestational hypertension and preeclampsia: ACOG practice bulletin summary, number 222. Obstet Gynecol. 2020, 135:1492-5. 10.1097\/AOG.0000000000003892","journal-title":"Obstet Gynecol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2021.09.008","article-title":"The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice","volume":"27","author":"Magee LA","year":"2022","unstructured":"Magee LA, Brown MA, Hall DR, et al.. The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2022, 27:148-69. 10.1016\/j.preghy.2021.09.008","journal-title":"Pregnancy Hypertens"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2019.07.004","article-title":"The two-stage placental model of preeclampsia: an update","volume":"134-5","author":"Staff AC","year":"2019","unstructured":"Staff AC. The two-stage placental model of preeclampsia: an update. J Reprod Immunol. 2019, 134-5:1-10. 10.1016\/j.jri.2019.07.004","journal-title":"J Reprod Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2008.11.009","article-title":"The two stage model of preeclampsia: variations on the theme","volume":"30","author":"Roberts JM","year":"2009","unstructured":"Roberts JM, Hubel CA. The two stage model of preeclampsia: variations on the theme. Placenta. 2009, 30:S32-7. 10.1016\/j.placenta.2008.11.009","journal-title":"Placenta"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2013.12.008","article-title":"IFPA Senior Award Lecture: making sense of pre-eclampsia - two placental causes of preeclampsia?","volume":"35","author":"Redman CW","year":"2014","unstructured":"Redman CW, Sargent IL, Staff AC. IFPA Senior Award Lecture: making sense of pre-eclampsia - two placental causes of preeclampsia?. Placenta. 2014, 35:S20-5. 10.1016\/j.placenta.2013.12.008","journal-title":"Placenta"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(97)00223-8","article-title":"Elevated homocyst(e)ine levels with preeclampsia","volume":"90","author":"Rajkovic A","year":"1997","unstructured":"Rajkovic A, Catalano PM, Malinow MR. Elevated homocyst(e)ine levels with preeclampsia. Obstet Gynecol. 1997, 90:168-71. 10.1016\/S0029-7844(97)00223-8","journal-title":"Obstet Gynecol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.49.1.31","article-title":"Homocysteine and cardiovascular disease","volume":"49","author":"Refsum H","year":"1998","unstructured":"Refsum H, Ueland PM, Nyg\u00e5rd O, Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med. 1998, 49:31-62. 10.1146\/annurev.med.49.1.31","journal-title":"Annu Rev Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9378(99)70269-3","article-title":"Changes in homocysteine levels during normal pregnancy","volume":"180","author":"Walker MC","year":"1999","unstructured":"Walker MC, Smith GN, Perkins SL, Keely EJ, Garner PR. Changes in homocysteine levels during normal pregnancy. Am J Obstet Gynecol. 1999, 180:660-4. 10.1016\/s0002-9378(99)70269-3","journal-title":"Am J Obstet Gynecol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9378(98)70033-x","article-title":"Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation","volume":"179","author":"Powers RW","year":"1998","unstructured":"Powers RW, Evans RW, Majors AK, Ojimba JI, Ness RB, Crombleholme WR, Roberts JM. Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation. Am J Obstet Gynecol. 1998, 179:1605-11. 10.1016\/s0002-9378(98)70033-x","journal-title":"Am J Obstet Gynecol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000151117.52952.b6","article-title":"Mapping the theories of preeclampsia: the role of homocysteine","volume":"105","author":"Mignini LE","year":"2005","unstructured":"Mignini LE, Latthe PM, Villar J, Kilby MD, Carroli G, Khan KS. Mapping the theories of preeclampsia: the role of homocysteine. Obstet Gynecol. 2005, 105:411-25. 10.1097\/01.AOG.0000151117.52952.b6","journal-title":"Obstet Gynecol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2020.10.027","article-title":"Postpartum preeclampsia or eclampsia: defining its place and management among the\u00a0hypertensive disorders of pregnancy","volume":"226","author":"Hauspurg A","year":"2022","unstructured":"Hauspurg A, Jeyabalan A. Postpartum preeclampsia or eclampsia: defining its place and management among the\u00a0hypertensive disorders of pregnancy. Am J Obstet Gynecol. 2022, 226:S1211-21. 10.1016\/j.ajog.2020.10.027","journal-title":"Am J Obstet Gynecol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2022.2110233","article-title":"High level of homocysteine is associated with pre-eclampsia risk in pregnant woman: a meta-analysis","volume":"38","author":"Zhang C","year":"2022","unstructured":"Zhang C, Hu J, Wang X, Gu H. High level of homocysteine is associated with pre-eclampsia risk in pregnant woman: a meta-analysis. Gynecol Endocrinol. 2022, 38:705-12. 10.1080\/09513590.2022.2110233","journal-title":"Gynecol Endocrinol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2001.117304","article-title":"Elevated plasma homocysteine in early pregnancy: a risk factor for the development of severe preeclampsia","volume":"185","author":"Cotter AM","year":"2001","unstructured":"Cotter AM, Molloy AM, Scott JM, Daly SF. Elevated plasma homocysteine in early pregnancy: a risk factor for the development of severe preeclampsia. Am J Obstet Gynecol. 2001, 185:781-5. 10.1067\/mob.2001.117304","journal-title":"Am J Obstet Gynecol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.0001-6349.2004.00291.x","article-title":"Plasma homocysteine in early and late pregnancies complicated with preeclampsia and isolated intrauterine growth restriction","volume":"83","author":"D'Anna R","year":"2004","unstructured":"D'Anna R, Baviera G, Corrado F, Ientile R, Granese D, Stella NC. Plasma homocysteine in early and late pregnancies complicated with preeclampsia and isolated intrauterine growth restriction. Acta Obstet Gynecol Scand. 2004, 83:155-8. 10.1111\/j.0001-6349.2004.00291.x","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurox.2023.100223","article-title":"Association of pre-pregnancy body mass index with early- and late-onset severe preeclampsia","volume":"19","author":"Sudjai D","year":"2023","unstructured":"Sudjai D. Association of pre-pregnancy body mass index with early- and late-onset severe preeclampsia. Eur J Obstet Gynecol Reprod Biol X. 2023, 19:100223. 10.1016\/j.eurox.2023.100223","journal-title":"Eur J Obstet Gynecol Reprod Biol X"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/ehjqcco\/qcad065","article-title":"Update on long-term cardiovascular risk after pre-eclampsia: a systematic review and meta-analysis","volume":"10","author":"Inversetti A","year":"2024","unstructured":"Inversetti A, Pivato CA, Cristodoro M, Latini AC, Condorelli G, Di Simone N, Stefanini G. Update on long-term cardiovascular risk after pre-eclampsia: a systematic review and meta-analysis. Eur Heart J Qual Care Clin Outcomes. 2024, 10:4-13. 10.1093\/ehjqcco\/qcad065","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38380.674340.E0","article-title":"Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies","volume":"330","author":"Duckitt K","year":"2005","unstructured":"Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ. 2005, 330:565. 10.1136\/bmj.38380.674340.E0","journal-title":"BMJ"},{"key":"ref21","unstructured":"Low-dose aspirin use for the prevention of preeclampsia and related morbidity and mortality. (2021). Accessed. May 14, 2026: https:\/\/www.acog.org\/clinical\/clinical-guidance\/practice-advisory\/articles\/2021\/12\/low-dose-aspirin-use-for-the-preve...."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.160785","article-title":"Postpartum hypertension","volume":"189","author":"Powles K","year":"2017","unstructured":"Powles K, Gandhi S. Postpartum hypertension. CMAJ. 2017, 189:E913. 10.1503\/cmaj.160785","journal-title":"CMAJ"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.116.003497","article-title":"Preeclampsia and future cardiovascular health: a systematic review and meta-analysis","volume":"10","author":"Wu P","year":"2017","unstructured":"Wu P, Haththotuwa R, Kwok CS, et al.. Preeclampsia and future cardiovascular health: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes. 2017, 10:e003497. 10.1161\/CIRCOUTCOMES.116.003497","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.124.073302","article-title":"Hypertension in pregnancy and postpartum: current standards and opportunities to improve care","volume":"151","author":"Countouris M","year":"2025","unstructured":"Countouris M, Mahmoud Z, Cohen JB, et al.. Hypertension in pregnancy and postpartum: current standards and opportunities to improve care. Circulation. 2025, 151:490-507. 10.1161\/CIRCULATIONAHA.124.073302","journal-title":"Circulation"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.19082\/3057","article-title":"The evaluation of serum homocysteine, folic acid, and vitamin B12 in patients complicated with preeclampsia","volume":"8","author":"Shahbazian N","year":"2016","unstructured":"Shahbazian N, Jafari RM, Haghnia S. The evaluation of serum homocysteine, folic acid, and vitamin B12 in patients complicated with preeclampsia. Electron Physician. 2016, 8:3057-61. 10.19082\/3057","journal-title":"Electron Physician"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/485781-maternal-serum-homocysteine-as-a-severity-linked-biomarker-across-the-spectrum-of-hypertensive-disorders-of-pregnancy-a-prospective-observational-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T10:28:43Z","timestamp":1779359323000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/485781-maternal-serum-homocysteine-as-a-severity-linked-biomarker-across-the-spectrum-of-hypertensive-disorders-of-pregnancy-a-prospective-observational-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.109335","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,21]]}}}